What are current 5-year and 10-year survival rates for colon cancer in the UK by stage?
This fact-check may be outdated. Consider refreshing it to get the most current information.
Executive summary
Current UK-wide five‑year survival for bowel (colorectal) cancer is reported at about 60% (five‑year survival reached 60% for diagnoses in 2010–2014) and almost 60% are predicted to survive ten years or more for recent diagnoses (Cancer Research UK) [1] [2]. Stage‑specific UK figures vary by dataset: international benchmarking shows stage‑4 five‑year survival in the UK around 8% for cohorts diagnosed 2010–2014, while other sources cite higher and lower numbers depending on methods and time periods [3] [4].
1. Survival headline numbers: what national sources say
Cancer Research UK and related UK briefings give the headline that almost 6 in 10 people diagnosed with bowel cancer today are predicted to survive at least ten years, and five‑year survival has risen to roughly “almost 60%” in recent years [1] [2]. NHS and government summaries repeatedly stress five‑year survival around 60% for colorectal disease in the 2010–2014 / 2016–2020 epochs used in national reporting [2] [5].
2. Stage matters: large international study with stage breakdowns
The International Cancer Benchmarking Partnership (ICBP SURVMARK‑2) analysed 386,870 patients diagnosed 2010–2014 across seven high‑income countries and reported stage‑specific 5‑year net survival for colon and rectal cancer. That project shows wide variation by stage and country and reports that UK patients with stage‑4 disease had among the lowest 5‑year survival—around 8% in the UK cohort for those years—while survival for localized disease was much higher [4] [3]. The ICBP team attributes international differences to later diagnosis in the UK and to treatment and registration differences [4].
3. NHS England figures: survival by stage for recent diagnoses
NHS England publishes net survival estimates by stage for cancers diagnosed 2015–2019 (follow‑up to 2020) and emphasises the expected pattern: stages 1–2 have high 1‑ and 5‑year net survival, stage 3 lower, and stage 4 much lower. NHS reporting shows that colorectal 1‑year net survival by stage ranges widely and that a substantial share of colorectal cases are still diagnosed at stage 4 (about 25.6% of staged colorectal cases in that dataset), which depresses overall survival statistics [6].
4. Conflicting or varying stage numbers: why estimates differ
Different sources report different stage‑specific rates because of period examined, whether they combine colon and rectal, age‑standardisation, and registry methods. For example, the ICBP figure for UK stage‑4 five‑year survival (~8%) [4] [3] contrasts with other non‑UK‑specific clinical summaries or US SEER‑based figures that put 5‑year distant/distant‑stage survival for colorectal cancers in the low teens to mid‑teens [7] [8]. The divergence reflects case mix, staging practice and the calendar years used [4].
5. Historic trend and inequality context
UK survival has improved markedly over decades — mortality has fallen and five‑ and ten‑year survival have risen — but UK outcomes still lag some comparable countries for colon cancer; five‑year survival was about 60% in 2010–2014, lower than Australia, Denmark or Japan in the same comparison [2] [9] [10]. Deprivation and late diagnosis remain important drivers: least‑deprived groups have higher five‑year survival than the most‑deprived [11] [1].
6. What the numbers mean for an individual patient
Stage‑specific survival statistics are population averages, not predictions for any one person. Net survival and relative survival estimates reflect survival compared with people without cancer and vary by age, fitness, treatment and tumour biology. Clinical tools and trials can refine prognosis (for example, scores for Dukes B / stage II predict 5‑ and 10‑year cancer‑specific survival within that group) but national tables are blunt instruments for an individual’s outlook [12] [13].
7. Bottom line and limitations of current reporting
Available UK sources give a clear overall picture: five‑year survival for colorectal cancer in UK populations in recent national reporting sits near 60% and ten‑year survival is “nearly 6 in 10” for people diagnosed today [1] [2]. For stage‑specific numbers, the best recent international staging analysis (ICBP) puts UK five‑year survival for stage‑4 colon/rectal at about 8% for 2010–2014 cohorts and shows materially better survival for early stages [4] [3]. Limitations: datasets cover differing years and mixes of colon vs rectal, and staging and registration practices vary between sources, so anyone needing precise stage‑by‑stage, up‑to‑date figures for clinical decision‑making should consult NHS England cancer survival tables and Cancer Research UK data dashboards linked above [6] [1].
Sources quoted: Cancer Research UK survival pages and data [1] [2], ICBP SURVMARK‑2 international stage analysis [4], NHS England stage survival tables [6], and contextual UK analyses on comparative survival and deprivation [3] [11].